# Use of Wharton Jelly Derived Mesenchymal Stem Cells for Knee Osteoarthrosis

> **NCT02963727** · PHASE1 · UNKNOWN · sponsor: **Hanan Jafar** · enrollment: 10 (estimated)

## Conditions studied

- Knee Osteoarthrosis

## Interventions

- **BIOLOGICAL:** Wharton Jelly derived mesenchymal stem cell

## Key facts

- **NCT ID:** NCT02963727
- **Lead sponsor:** Hanan Jafar
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-27
- **Primary completion:** 2021-10
- **Final completion:** 2021-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02963727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02963727, "Use of Wharton Jelly Derived Mesenchymal Stem Cells for Knee Osteoarthrosis". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT02963727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*